Rebalance’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Rebalance’s Portfolio IBDT Stock Details IBDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.2M	Sell	682,885 -40,396	-6%	-$1.02M	0.9%	17
2026 Q1	$18.3M	Sell	723,281 -10,788	-1%	-$274K	1.06%	16
2025 Q4	$18.7M	Buy	734,069 +340,113	+86%	+$8.66M	1.09%	15
2025 Q3	$10.1M	Buy	393,956 +224,974	+133%	+$5.72M	0.61%	18
2025 Q2	$4.3M	Buy	168,982 +1,579	+0.9%	+$39.8K	0.29%	28
2025 Q1	$4.23M	Buy	167,403 +28,115	+20%	+$704K	0.31%	28
2024 Q4	$3.47M	Buy	+139,288	New	+$3.5M	0.26%	29

Other funds holding IBDT

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Rebalance's IBDT Position: Q2 2026 in Review

Rebalance reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 5.6% in Q2 2026, selling an estimated $1.02M and leaving 682,885 shares worth $17.2M. The position accounts for 0.9% of the portfolio, ranked #17.

Rebalance first reported a position in IBDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.7M in Q4 2025. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

Rebalance held 682,885 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $17.2M as of Q2 2026.
Rebalance sold 40,396 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $1.02M.
iShares iBonds Dec 2028 Term Corporate ETF made up 0.9% of Rebalance's portfolio in Q2 2026, its #17 holding.
Rebalance first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
Rebalance's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $18.7M in Q4 2025.
435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.